Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* a gestational age of 23 0/7-27 6/7 weeks,~* a postnatal age \< 12 hours~* the necessity for any form of positive pressure support (mechanical or nasal ventilation or CPAP~Exclusion Criteria:~* involve a clinical decision not to administer therapies (infant not considered viable)~* dysmorphic features or congenital malformations that adversely affect life expectancy or neurodevelopment and known or suspected congenital heart disease

- Gender: ALL
- Minimum Age: None
- Maximum Age: 12 Hours
- Healthy Volunteers: f

Study Arms:
- inhaled Budesonide (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).